Literature DB >> 109502

Further characterization of thymic suppressor cells and a factor that suppress the generation of cells cytotoxic for a syngeneic tumor in DBA/2 mice.

J G Levy, T Maier, D G Kilburn.   

Abstract

Antigen-specific suppressor cells and suppressive extracts obtained from the thymuses of DBA/2 mice bearing small syngeneic P815 mastocytomas were compared for their immunogenetic properties and requirements. The assay for specific suppression involved the ability of either cells or extracts to inhibit the primary in vitro cytotoxic response of normal DBA/2 splenocytes to mitomycin-treated P815 cells. It was shown that pretreatment of suooressor cell populations with anti-Iad antiserum plus rabbit complement removed the suppressive activity. Similarly, absorption of the suppressor factor with anti-Iad antiserum removed the suppressive properties of the material. It was found that the suppressor cells, generated in DBA/2 tumor bearers, were capable of specifically suppressing the anti-P815 response of B6D2 F1 radiation chimeras possessing lymphoid cells of the H-2b or H-2t2 haplotype equally as well as they could suppress the response of H-2d-bearing effector cells. This indicates that the suppressor cells are not H-2 restricted with respect to K or D markers on the responder cells in this system.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 109502

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Atrophy of the thymic cortex in mice with granulomatous schistosomiasis mansoni.

Authors:  S R Wellhausen; D L Boros
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

2.  An analysis of T lymphocyte subsets in tumour-transplanted mice on the basis of Lyt antigenic markers and functions.

Authors:  P K Lala; I F McKenzie
Journal:  Immunology       Date:  1982-12       Impact factor: 7.397

3.  Anti-tumor effects of an antiserum raised in syngeneic mice to a tumor-specific T suppressor factor.

Authors:  T Maier; J G Levy
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.